Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

Norwegian Pharma AS

Closing information (x1000 DKK)

Closing information 2022/12 2021/12 2020/12
Turnover 7,673 More Arrow 8,497 More Arrow 11,229
Financial expenses 30 More Arrow 38 More Arrow 83
Earnings before taxes 1,428 More Arrow 1,766 More Arrow 3,440
Total assets 4,860 More Arrow 6,752 More Arrow 9,464
Current assets 4,860 More Arrow 6,752 More Arrow 9,464
Current liabilities 1,279 Less Arrow 1,162 More Arrow 1,220
Equity capital 3,582 More Arrow 5,589 More Arrow 8,244
- share capital 71 More Arrow 75 Less Arrow 71

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 73.7% More Arrow 82.8% More Arrow 87.1%
Turnover per employee
Profit as a percentage of turnover 18.6% More Arrow 20.8% More Arrow 30.6%
Return on assets (ROA) 30.0% Less Arrow 26.7% More Arrow 37.2%
Current ratio 380.0% More Arrow 581.1% More Arrow 775.7%
Return on equity (ROE) 39.9% Less Arrow 31.6% More Arrow 41.7%
Change turnover -377 Less Arrow -3,337 More Arrow 201
Change turnover % -5% Less Arrow -28% More Arrow 2%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.